Vassiliki Spiliopoulou

3PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.

Ioannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis

|Sep 27, 2023
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.

Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou

|Jul 29, 2023
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma.

Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou

Pageof 1

Frequent Collaborators

3 joint publications

Ioannis Ntanasis-Stathopoulos

3 joint publications

Panagiotis Malandrakis

3 joint publications

Despina Fotiou

3 joint publications

Magdalini Migkou